Serendip develops solutions and processes that combine advanced technology with environmental compatibility, providing high added value for manufacturers of creams, gels, lotions and ointments in the life sciences sector.
Develops in-vitro models of cell and tissue systems. They simulate the transport of substances and formulations across biological barriers, from which conclusions regarding permeability and absorption can be drawn.
The company is a service partner for all aspects of oligonucleotides. It developed and produced the world's first and only translucent orthodontic systems using novel nanotechnology polymer composite products.
Serving as a contract research organization, Endotherm Life Science Molecules is a provider of medicinally relevant compounds for the discovery and development of novel small molecule drugs. The product range includes focused compound libraries, building blocks and reagents for the development of biochemical assays (fluorescent and bioluminescent dyes).
Genovoxx is developing a technology for the massively parallel sequencing by synthesis of nucleic acids. This technology enables the sequencing of many millions of nucleic acids molecules in parallel format at the single molecule level.
(German language site) The company is a Contract Research Organisation for the development and improvement of advanced cell culture systems for industrial drug screening applications, biomaterial testing and pharma-toxicological research.
Primary goals of the company are the development and the establishment of innovative bioinstrumentation based on Femtosecond Laser Technology for biotechnology, cell biology and medicine, e.g. nanoprocessing with femtosecond near infrared laser pulses.
The main focus of our company is the development of precision scientific measuring instrumentation and equipment for research groups at universities and for the pharmaceutical industry, in the field of electrophysiology. MCS products reduce the labor intensive measuring and analyzing processes through miniaturization and automation.
NanoTemper Technologies GmbH, a Spin-Off of the Ludwig-Maximilians-University Munich, was founded in May 2008 in order to provide analytical services to pharmaceutical industry, biotechnology and research institues.
nanoTools provides monoclonal and polyclonal antibody development services and products. Besides providing individually tailored custom solutions, the company develops, manufactures and markets phosphorylation and modification - state specific monoclonal antibodies and other innovative reagents for Signal Transduction and Alzheimer research, high throughput screening (HTS) and proteomics.